Other analysts also recently issued research reports about the company. Liberum Capital reiterated a buy rating on shares of Udg Healthcare in a research report on Thursday, November 22nd. Jefferies Financial Group upgraded Udg Healthcare to a buy rating and dropped their price target for the company from GBX 895 ($11.69) to GBX 890 ($11.63) in a research report on Thursday, August 9th. Barclays reiterated an equal weight rating on shares of Udg Healthcare in a research report on Friday, September 28th. Berenberg Bank reiterated a hold rating and set a GBX 750 ($9.80) price target on shares of Udg Healthcare in a research report on Tuesday, November 27th. Finally, Numis Securities reiterated a hold rating and set a GBX 660 ($8.62) price target on shares of Udg Healthcare in a research report on Tuesday, November 27th. Four investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The stock currently has an average rating of Buy and a consensus price target of GBX 826.22 ($10.80).
Shares of UDG opened at GBX 635.50 ($8.30) on Thursday. Udg Healthcare has a 12-month low of GBX 690 ($9.02) and a 12-month high of GBX 963 ($12.58).
In other news, insider Peter Gray acquired 14,000 shares of the firm’s stock in a transaction that occurred on Wednesday, September 19th. The shares were bought at an average cost of GBX 631 ($8.25) per share, with a total value of £88,340 ($115,431.86). Also, insider Myles Lee sold 6,000 shares of the firm’s stock in a transaction dated Tuesday, November 27th. The shares were sold at an average price of GBX 590 ($7.71), for a total value of £35,400 ($46,256.37).
Udg Healthcare Company Profile
UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services to the healthcare industry in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates through three segments: Ashfield, Sharp, and Aquilant.
Featured Story: What are Closed-End Mutual Funds?
Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.